Flow cytometric analysis of CD4+ T cell re-activation following anti-PD1 immunotherapy in a transgenic mouse model

Lozan Sheriff, David Bending*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

21 Downloads (Pure)

Abstract

This protocol uses the Tg4 Nr4a3-Tocky mouse model to recalibrate T cell activation thresholds and reveals the role that immune checkpoints play in controlling T cell activation. The example approach here uses flow cytometry to characterize quantitative and qualitative changes in splenic CD4+ T cells reactivated in the presence of anti-PD1 immunotherapy. The protocol is optimized for studying anti-PD1 pathway blockade only. The protocol is not compatible with cellular fixation, and T cells should be analyzed immediately after staining.

For complete details on the use and execution of this protocol, please refer to Elliot et al. (2021).
Original languageEnglish
Article number101161
Number of pages11
JournalSTAR Protocols
Volume3
Issue number1
Early online date3 Feb 2022
DOIs
Publication statusPublished - 18 Mar 2022

Bibliographical note

Funding Information:
This work is funded by the MRC ( MR/V009052/1 ). The graphical abstract and Figure 1 were created using https://biorender.com .

Publisher Copyright:
© 2022 The Author(s)

Keywords

  • Cancer
  • Cell Biology
  • Flow Cytometry/Mass Cytometry
  • Immunology
  • Model Organisms

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Neuroscience(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Fingerprint

Dive into the research topics of 'Flow cytometric analysis of CD4+ T cell re-activation following anti-PD1 immunotherapy in a transgenic mouse model'. Together they form a unique fingerprint.

Cite this